ANIP · Ani Pharmaceuticals Inc · Documents
Market Cap
$1.61B
Shares
22.97M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-24 | 2026-08-19 | |
| 8-K | 2026-08-07 | — | |
| 10-Q | 2026-08-07 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-08 | — | |
| DEF 14A | 2026-04-09 | 2025-12-31 | |
| 8-K | 2026-04-07 | 2026-04-01 | |
| 8-K | 2026-03-03 | — | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2026-02-27 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-01 | 2025-11-24 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-07 | — | |
| 8-K | 2025-09-26 | — | |
| 8-K | 2025-09-08 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-08 | — | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 8-K | 2025-05-20 | — | |
| 8-K | 2025-05-09 | — | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-08 | 2025-05-06 | |
| DEF 14A | 2025-04-10 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-14 | — | |
| 8-K | 2025-03-11 | — | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2025-02-05 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-20 | — | |
| 8-K | 2024-11-08 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-09-20 | 2024-09-16 | |
| 8-K | 2024-09-16 | — | |
| 8-K | 2024-08-13 | 2024-08-07 | |
| 8-K | 2024-08-08 | 2024-08-07 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-24 | 2024-06-21 |
Showing 1–50 of 140 filings
Key facts
CIK
1023024
CUSIP
00182C103
13F (30d)
195 filings
194 filers
Visit website
Investor relations